Rebound in the incidence of pneumococcal meningitis in northern France: Effect of serotype replacement

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 11, 2010, Pages 1686-1690

  Alexandre, C ^a   Dubos, F ^a,d   Courouble, C ^b   Pruvost, I ^a   Varon, E ^c   Martinot, A ^a  

^a UNIV LILLE   (France)

^b Department of Addictology Le Square   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Paediatric Emergency and Infectious Diseases Unit   (France)

Author keywords

Conjugate vaccine; Epidemiology; Meningitis; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ACUTE SINUSITIS; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; INCIDENCE; INFANT; MALE; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REBOUND; SCHOOL CHILD; SEROTYPE;

EID: 78649759328     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01914.x     Document Type: Article

References (27)

1. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007; 82: 93-104.
2. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000; 49: 1-35.
3. Bingen E, Levy C, Varon E, De la Rocque F, Boucherat M, d'Athis P, et al. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis 2008; 27: 191-9.
4. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102: 1087-97.
5. Casado-Flores J, Aristegui J, de Liria CR, Martinón JM, Fernández C; Spanish Pneumococcal Meningitis Study Group. Clinical data and factors associated with poor outcome in pneumococcal meningitis. Eur J Pediatr 2006; 165: 285-9.
6. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am 2008; 38: 281-317.
7. Floret D. Bacterial meningitis due to resistant strains of Streptococcus pneumoniae. Arch Pediatr 2002; 9: 1166-72.
8. Hsu H, Shutt K, Moore M, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360: 244-56.
9. Bingen E, Lévy C, De la Rocque F, Boucherat M, Aujard Y, Cohen R, et al. Pneumococcal meningitis in France: Age and medical risk factors in children. Arch Pediatr 2005; 12: 1187-9.
10. Jefferson T, Ferroni E, Curtale F, Giorgi Rossi P, Biorgia P. Streptococcus pneumonia in western Europe: Serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 2006; 6: 405-10.
11. Avis du conseil supérieur d'hygiène publique de France du 8 mars 2002, relatif àla vaccination par le vaccin pneumococcique heptavalent conjugué (Prevenar). Available at: Http://www.sante.gouv.fr
12. Avis du conseil supérieur d'hygiène publique de France du 19 mai 2006 relatif àla vaccination par le vaccin anti-pneumococcique conjugué chez les enfants de moins de deux ans et les enfants de deux àcinq ans. Available at: Http://www.sante. gouv.fr
13. Kaplan SL, Mason EO, Wald ER. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004; 113: 443-9.
14. Lepoutre A, Varon E, Georges S, Gutman L, Lévy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 2008; 13: 7-9.
15. Casado-Flores J, Rodrigo C, Arístegui J, Martínón JM, Fenoll A, Mendez C. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008; 27: 1020-2.
16. Dubos F, Marechal I, Husson MO, Courouble C, Aurel M, Martinot A, et al. Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France. Arch Dis Child 2007; 92: 1009-12.
17. Center KJ. Prevenar vaccination: Review of the global data, 2006. Vaccine 2007; 25: 3085-9.
18. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) Serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196: 1346-54.
19. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187: 1424-32.
20. Dubos F, Marechal I, Tilmont B, Courouble C, Leclerc F, Martinot A. Incidence of invasive meningococcal diseases in children in Northern France: Usefulness and limits of the discharge code database for correcting compulsory notification data. Arch Pediatr 2009; 16: 984-90.
21. Helou D, Moukagni-Pelzer M, Hoeusler-Vassant V, Huvenne H, El-Kohen R, Raymond J, et al. Pneumococcal conjugate vaccine coverage in a hospital center of the Metropolis of Lille in 2008. Med Mal Infect 2010. [Epub ahead of print].
22. Dagan R, Givon-Lavi N, Greenberg D, Fritzell B, Siegriest CA. Pneumococcal nasopharyngeal carriage at time of 7 valent pneumococcal conjugate vaccine administration is associated with serotype specific hyporesponsiveness in early infancy. In: ICAAC 2008 (Abstract:G2-3740).
23. Johnsborg O, Hå varstein LS. Regulation of natural genetic transformation and acquisition of transforming DNA in Streptococcus pneumoniae. FEMS Microbiol Rev 2009; 33: 627-42.
24. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003; 21: 1815-25.
25. O'Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007; 196: 1211-20.
26. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008; 8: 785-95.
27. Varon E, Janoir C, Gutmann L. Rapport d'activité 2008 du Centre National de Référence des Pneumocoques. Available at: Http://www.invs.sante.fr/surveillance/cnr/rapports- pneumocoques2008.pdf (accessed on February 2010).